In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CytoTools GmbH

http://www.cytotools.de

Latest From CytoTools GmbH

CytoTools pins hopes on wound healing agent DermaPro

CytoTools, the holding company of DermaTools Biotech, has a lot riding on DermaTools' wound healing agent DermaPro (diperoxochloric acid), the latter's first product which is now heading towards potential commercialisation.

Dermatology Wound Healing & Tissue Repair

Deals Shaping the Medical Industry (11/2009)

The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.

Pieris Proteolab AG

Pieris ProteoLab was founded in February 2001 to commercialize anticalins, a novel class of antibody mimetics based on a lipocalin scaffold. Due to their molecular architecture, anticalins offer some distinct advantages over antibodies; Pieris will exploit these advantages in developing new drugs for oncology and inflammatory diseases.

BioPharmaceutical Europe
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
UsernamePublicRestriction

Register